A new muscle chaperonopathy associated with DNAJB4

• An international team of doctors and researchers has discovered a new muscle form of chaperonopathy in four patients from three families, two in Spain and one in Saudi Arabia, who had not previously been genetically diagnosed.

• The clinical examination of these patients indicates:

  • a manifestation of the disease between the 1st and 4th decade;
  • early respiratory failure and vertebral rigidity in all patients;
  • axial hypotonia (with Beevor’s sign) and cardiomyopathy observed independently in two patients;
  • no developmental delay or limb weakness.

• MRI shows:

  • specific involvement of the muscles of the posterior part of the thigh (biceps femoris and semitendinosus), while the anterior part is spared;
  • damage to the gluteus maximus muscle in one patient and the calf muscle (soleus) in another.

• The muscle biopsies show:

  • atrophied fibres, occasionally angular and more rarely necrotic;
  • inclusion bodies and bordered vacuoles.

• Creatine kinase levels range from normal to three times the upper limit of normal.

• Exome sequencing reveals three homozygous mutations in the DNAJB4 gene: one nonsense mutation (c.856A > T; p.Lys286Ter) and two missense mutations (c.74G > A; p.Arg25Gln and c.785 T > C; p.Leu262Ser). The latter two lead to the production of a protein that is either degraded by the cell or stable but non-functional.

• None of the heterozygous mutation carriers were affected by the disease.

 

Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure. Weihl, C. C., Töpf, A., Bengoechea, R., et al. Acta Neuropathol. 2022.